Texas 2019 - 86th Regular

Texas House Bill HB767 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	86R349 KFF-D
2	2	By: Davis of Harris H.B. No. 767
3	3
4	4
5	5	A BILL TO BE ENTITLED
6	6	AN ACT
7	7	relating to the evaluation of and reporting on certain Medicaid
8	8	waiver projects.
9	9	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
10	10	SECTION 1. Subchapter B, Chapter 531, Government Code, is
11	11	amended by adding Section 531.021111 to read as follows:
12	12	Sec. 531.021111. SECTION 1115 WAIVER PROJECTS: FINAL
13	13	EVALUATION REPORTS; REPORT TO LEGISLATURE. (a) In this section:
14	14	(1) "Section 1115 waiver program" means a federally
15	15	funded program of the state under Medicaid that is authorized under
16	16	Section 1115 of the federal Social Security Act (42 U.S.C. Section
17	17	1315).
18	18	(2) "Waiver project" means any experimental, pilot, or
19	19	demonstration project implemented by an entity other than a state
20	20	agency and funded, wholly or partly, using federal money received
21	21	under a Section 1115 waiver program.
22	22	(b) The commission shall require each entity that receives
23	23	funding to implement a waiver project in this state to, not later
24	24	than the 30th day after the date the period authorized for the
25	25	project terminates and regardless of whether the project is
26	26	continuing for another period, submit a final evaluation report to
27	27	the commission. A final evaluation report must:
28	28	(1) be based on:
29	29	(A) quantitative research methods involving the
30	30	empirical investigation of the impact of key programmatic features
31	31	of the waiver project; or
32	32	(B) if quantitative designs are technically
33	33	infeasible or not well suited to the change sought by the waiver
34	34	project, an alternative design approved by the commission;
35	35	(2) minimize the burden on recipients and project
36	36	recipient privacy while ensuring the impact of the waiver project
37	37	is measured;
38	38	(3) discuss the hypothesis being tested by the waiver
39	39	project;
40	40	(4) discuss the data used to conduct the evaluation,
41	41	including monitoring and reporting conducted during the waiver
42	42	project and the methods used for collecting the data;
43	43	(5) include a description of how the effects of the
44	44	waiver project are isolated from other factors that may contribute
45	45	to the change sought; and
46	46	(6) include any other information the commission
47	47	determines appropriate.
48	48	(c) The commission shall, as soon as practicable, but not
49	49	later than the 30th day after the date the commission receives a
50	50	final evaluation report under this section:
51	51	(1) submit a copy of the report along with the
52	52	commission's recommendations regarding the continuation of the
53	53	waiver project to the standing committees of the senate and house of
54	54	representatives with jurisdiction over Medicaid; and
55	55	(2) make a copy of the report available to the public
56	56	on the commission's Internet website.
57	57	(d) The commission's recommendations under Subsection
58	58	(c)(1) must:
59	59	(1) include a statement regarding whether the waiver
60	60	project should be modified in any manner, made permanent,
61	61	eliminated, or extended to allow more time for review; and
62	62	(2) provide justification for the recommendations,
63	63	including a detailed cost-benefit analysis of the waiver project.
64	64	SECTION 2. If before implementing any provision of this Act
65	65	a state agency determines that a waiver or authorization from a
66	66	federal agency is necessary for implementation of that provision,
67	67	the agency affected by the provision shall request the waiver or
68	68	authorization and may delay implementing that provision until the
69	69	waiver or authorization is granted.
70	70	SECTION 3. This Act takes effect September 1, 2019.